Skip to main content
POAS logo

Phaos Technology Holdings (Caym (POAS) Stock Price & Analysis

Phaos Technology Holdings (Caym (POAS) — MoonshotScore 31/100 (Weak band), calculated Nov 18, 2026. Price $2.32 (+11.00%), as of the Nov 18, 2026 trading session; market cap $37.6M.

Educational signal · not a buy or sell recommendation · How to read this

$2.32 +$0.23 (+11.00%) Market Cap $37.6M

Phaos Technology Holdings (Caym · POAS

Phaos Technology Holdings (Cayman) Limited specializes in the manufacturing and commercialization of advanced microscopy solutions, technologies, and products in Singapore. The company serves diverse sectors including manufacturing, biomedical service providers, and research and development institutions with its range of specialized imaging and measurement systems.

Price as of Nov 18, 2026

Key Statistics

31 of 100

MoonshotScore v2 · Phaos Technology Holdings (Caym (POAS)

Weak
Business Quality Poor (7)
Financial Safety Strained (27)
Valuation Bubble (11)
Growth Durability Shrinking (6)
Momentum Slipping (20)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Bottom-tier quality, a strained balance sheet and stalling growth, and it’s expensive on top — broad distress, a capital-preservation call, not a value entry. The score also carries a risk penalty for being loss-making and burning cash. Business Quality: Poor; Financial Safety: Strained; Valuation: Bubble; Growth Durability: Shrinking; Momentum: Slipping.

  • quarterly revenue S$36,303 (Q4 FY2025, quarter ended Apr 30, 2026)

Holding back: weak fundamentals, balance-sheet strain, a rich price, soft growth, weak price trend

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for POAS (52 recorded, newest six shown)
RecordedScoreBand
30Weak
30Weak
30Weak
30Weak
31Weak
31Weak

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$2.32
Change on the day+11.00%
52-week range$0.5265 – $111.00
Market capitalisation$37.6M—
Shares traded on the day146.2K

Price & events

Other perspectives

Council score for Phaos Technology Holdings (Caym (POAS): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Negative
Financial Safety Weak
Valuation Negative
Growth Durability Negative
Momentum Weak

Legends Council

5 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Unfavorable read

Read on: Sep 3, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Negative
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Negative
Debt/Equity Strong
ROE Negative
Gross Margin Weak

Read on: Jun 1, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Jun 1, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Phaos Technology Holdings (Caym (POAS), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Phaos Technology Holdings (Caym (POAS) is the company analyzed here. It employs 10 people and is led by Hong Loon Gan. In Q4 FY2025 it reported revenue of S$36,303 and net income of -S$4M. The market values it at $37.6M.

2 · Latest results

What do the latest results show for Phaos Technology Holdings (Caym (POAS)?

Short answer · as of

The most recent reported quarter, Q4 FY2025, carried revenue of S$36,303.

Quarterly income statement — 3 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q4 FY2025S$36,303-S$4M-S$3.30 (diluted)
Q2 FY2025S$68,083-S$1M-S$0.56 (diluted)
Q2 FY2024S$31,564-S$1M-S$0.59 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Phaos Technology Holdings (Caym (POAS)?

Short answer · as of

What is holding it back is weak fundamentals, balance-sheet strain, a rich price, soft growth, weak price trend. Trailing ratios: ROA -91.9% · current ratio 4.01 · earnings yield -104.2%.

5 · Peer comparison

How does Phaos Technology Holdings (Caym compare with its peers?

Short answer

Phaos Technology Holdings (Caym's score ranks 13th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Viemed Healthcare, Inc. (VMD) Same industry, near in market value$8.78 Nov 18, 2026$333M88 5-pillar Nov 18, 2026
Electromed, Inc. (ELMD) Same industry, near in market value$23.40 Nov 18, 2026$191M87 5-pillar Nov 18, 2026
BrainsWay Ltd. (BWAY) Same industry, near in market value$8.98 Nov 18, 2026$361M87 5-pillar Nov 18, 2026
Anika Therapeutics, Inc. (ANIK) Same industry, near in market value$13.62 Nov 18, 2026$182M71 5-pillar Nov 18, 2026
LENSAR, Inc. (LNSR) Same industry, near in market value$4.85 Nov 18, 2026$59.6M44 5-pillar Nov 18, 2026
Solana Company (HSDT) Same industry, near in market value$1.63 Nov 18, 2026$103M43 5-pillar Nov 18, 2026
Owlet, Inc. (OWLT) Same industry, near in market value$3.67 Nov 18, 2026$110M41 5-pillar Nov 18, 2026
Hyperion DeFi, Inc. (HYPD) Same industry, near in market value$2.38 Nov 18, 2026$36.2M39 5-pillar Nov 18, 2026
Inogen, Inc. (INGN) Same industry, near in market value$5.57 Nov 18, 2026$145M37 5-pillar Nov 18, 2026
Orthofix Medical Inc. (OFIX) Same industry, near in market value$6.61 Nov 18, 2026$269M36 5-pillar Nov 18, 2026
908 Devices Inc. (MASS) Same industry, near in market value$9.52 Nov 18, 2026$396M35 5-pillar Nov 18, 2026
Apyx Medical Corporation (APYX) Same industry, near in market value$2.49 Nov 18, 2026$105M33 5-pillar Nov 18, 2026
Phaos Technology Holdings (Caym (POAS) — this page$2.32$37.6M31

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held POAS in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported POAS in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Phaos Technology Holdings (Caym (POAS)?

Read these with our analysis →

What Investors Ask About Phaos Technology Holdings (Caym (POAS)

These answers are editorial: 1 of these 9 answers is drawn from the POAS research dossier (written Jun 15, 2026 by gemini-2.5-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for POAS?

POAS carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is POAS a good stock to buy?

Stock Expert AI does not rate POAS buy, sell or hold. Phaos Technology Holdings (Caym carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the POAS stock price today?

The last price recorded for Phaos Technology Holdings (Caym (POAS), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What revenue streams does Phaos Technology Holdings (Caym have in healthcare and other sectors?

Phaos Technology Holdings generates revenue primarily through the manufacturing and commercialization of its advanced microscopy solutions. In the healthcare sector, revenue streams are derived from the sale of systems like PT-Biology, which are used by biomedical service providers and research institutions for specialized imaging.

What are the key factors to evaluate for POAS?

Phaos Technology Holdings (Caym (POAS) holds a MoonshotScore in the low range. Custom Solutions for Specialized Research Institutions: Research and development institutions often require highly customized microscopy solutions for unique experimental setups or novel scientific inquiries. Not financial advice.

How frequently does POAS data refresh on this page?

POAS's price is the last quote we recorded, from the Nov 18, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven POAS's recent stock price performance?

Phaos Technology Holdings (Caym (POAS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized product range in advanced microscopy, addressing niche market demands. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider POAS overvalued or undervalued right now?

Phaos Technology Holdings (Caym (POAS) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research POAS before investing?

Before investing in Phaos Technology Holdings (Caym (POAS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 13 figures on this page — 7 from Financial Modeling Prep (FMP), 5 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.